J. Curram

595 total citations
15 papers, 380 citations indexed

About

J. Curram is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, J. Curram has authored 15 papers receiving a total of 380 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pulmonary and Respiratory Medicine, 5 papers in Cardiology and Cardiovascular Medicine and 4 papers in Pathology and Forensic Medicine. Recurrent topics in J. Curram's work include Pulmonary Hypertension Research and Treatments (5 papers), Systemic Sclerosis and Related Diseases (4 papers) and Dermatologic Treatments and Research (3 papers). J. Curram is often cited by papers focused on Pulmonary Hypertension Research and Treatments (5 papers), Systemic Sclerosis and Related Diseases (4 papers) and Dermatologic Treatments and Research (3 papers). J. Curram collaborates with scholars based in United Kingdom, United States and Italy. J. Curram's co-authors include Owen Collins, David F. Edwards, Marco Matucci‐Cerinic, Yannick Allanore, Dinesh Khanna, Janet Pope, Oliver Distler, Christopher P. Denton, Geoff Hackett and Janethe de Oliveira Pena and has published in prestigious journals such as Clinical Infectious Diseases, Stroke and Annals of the Rheumatic Diseases.

In The Last Decade

J. Curram

15 papers receiving 371 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. Curram United Kingdom 8 173 120 120 59 54 15 380
Amelia Santosa Singapore 12 63 0.4× 148 1.2× 58 0.5× 76 1.3× 17 0.3× 49 433
Huan‐Fa Hsieh Taiwan 10 58 0.3× 86 0.7× 88 0.7× 30 0.5× 23 0.4× 23 417
Muhammet Çınar Türkiye 13 42 0.2× 77 0.6× 68 0.6× 11 0.2× 35 0.6× 68 475
Herman Ellman United States 13 30 0.2× 108 0.9× 87 0.7× 8 0.1× 24 0.4× 22 420
Sachie Inoue Japan 11 44 0.3× 106 0.9× 25 0.2× 9 0.2× 26 0.5× 39 363
Elizabeth Faust United States 11 30 0.2× 22 0.2× 25 0.2× 27 0.5× 50 0.9× 21 321
Ercan Türkmen Türkiye 9 33 0.2× 12 0.1× 90 0.8× 55 0.9× 11 0.2× 32 314
John W. Blackett United States 14 111 0.6× 18 0.1× 48 0.4× 103 1.7× 13 0.2× 35 453
Erdal Uysal Türkiye 8 31 0.2× 89 0.7× 81 0.7× 11 0.2× 5 0.1× 41 303
Yusuf Kayar Türkiye 11 187 1.1× 22 0.2× 35 0.3× 15 0.3× 12 0.2× 72 515

Countries citing papers authored by J. Curram

Since Specialization
Citations

This map shows the geographic impact of J. Curram's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Curram with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Curram more than expected).

Fields of papers citing papers by J. Curram

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Curram. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Curram. The network helps show where J. Curram may publish in the future.

Co-authorship network of co-authors of J. Curram

This figure shows the co-authorship network connecting the top 25 collaborators of J. Curram. A scholar is included among the top collaborators of J. Curram based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Curram. J. Curram is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Becker, Mike Oliver, Nicole Graf, Rafael Sauter, et al.. (2019). Predictors of disease worsening defined by progression of organ damage in diffuse systemic sclerosis: a European Scleroderma Trials and Research (EUSTAR) analysis. Annals of the Rheumatic Diseases. 78(9). 1242–1248. 40 indexed citations
2.
Jordan, Suzana, Nicole Graf, Janethe de Oliveira Pena, et al.. (2019). Progressive skin fibrosis is associated with a decline in lung function and worse survival in patients with diffuse cutaneous systemic sclerosis in the European Scleroderma Trials and Research (EUSTAR) cohort. Annals of the Rheumatic Diseases. 78(5). 648–656. 83 indexed citations
3.
4.
Becker, Mike Oliver, Norbert Graf, Rafael Sauter, et al.. (2018). FRI0456 Predictors for disease worsening defined by organ failure in diffuse systemic sclerosis: a european scleroderma trials and research (EUSTAR) analysis. Annals of the Rheumatic Diseases. 77. 757–758. 1 indexed citations
5.
Wang, Chen, Zhi‐Cheng Jing, Yigao Huang, et al.. (2016). Riociguat for the treatment of pulmonary hypertension: Chinese subgroup analyses and comparison. Heart Asia. 8(1). 74–82. 5 indexed citations
6.
D’Armini, Andrea Maria, Hossein Ardeschir Ghofrani, Nick H. Kim, et al.. (2015). Use of responder threshold criteria to evaluate the response to treatment in the phase III CHEST-1 study. The Journal of Heart and Lung Transplantation. 34(3). 348–355. 11 indexed citations
7.
Langleben, David, Nazzareno Galiè, Jianguo He, et al.. (2014). Use of clinically relevant responder threshold criteria to evaluate the response to treatment in the Phase III PATENT-1 study. The Journal of Heart and Lung Transplantation. 34(3). 338–347. 9 indexed citations
8.
Grieve, Andrew P., J. Curram, Lutz Harnisch, et al.. (2013). Advancing Clinical Trial Design in Pulmonary Hypertension. Pulmonary Circulation. 3(1). 217–225. 14 indexed citations
9.
Grünig, Ekkehard, Mirko Sikirica, J. Curram, Neil Davie, & Hossein Ardeschir Ghofrani. (2013). Riociguat for the Treatment of Patients with Pulmonary Arterial Hypertension (PAH): Responder Analysis of Who Functional Class III Patients from the Patent-1 Study. Value in Health. 16(7). A513–A513. 1 indexed citations
10.
Ali, Myzoon, Philip M. Bath, J. Curram, et al.. (2007). The Virtual International Stroke Trials Archive. Stroke. 38(6). 1905–1910. 93 indexed citations
11.
Edwards, David F., Geoff Hackett, Owen Collins, & J. Curram. (2006). VARDENAFIL IMPROVES SATISFACTION IN COUPLES AFFECTED BY ERECTILE DYSFUNCTION PREVIOUSLY UNTREATED WITH PDE5 INHIBITORS. European Urology Supplements. 5(2). 177–177. 2 indexed citations
12.
13.
Kennedy, N., L. Berger, J. Curram, et al.. (1996). Randomized Controlled Trial of a Drug Regimen That Includes Ciproftoxacin for the Treatment of Pulmonary Tuberculosis. Clinical Infectious Diseases. 22(5). 827–833. 68 indexed citations
14.
Marley, John & J. Curram. (1989). Body mass index and diastolic blood pressure. BMJ. 299(6707). 1102.3–1102. 1 indexed citations
15.
Curram, J., et al.. (1989). General Practice Data Derived Tolerability Assessment of Antihypertensive Drugs. Journal of International Medical Research. 17(5). 473–478. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Amelia Santosa Breakdown of academic impact, for papers by Huan‐Fa Hsieh Breakdown of academic impact, for papers by Muhammet Çınar Breakdown of academic impact, for papers by Herman Ellman Breakdown of academic impact, for papers by Sachie Inoue Breakdown of academic impact, for papers by Elizabeth Faust Breakdown of academic impact, for papers by Ercan Türkmen Breakdown of academic impact, for papers by John W. Blackett Breakdown of academic impact, for papers by Erdal Uysal Breakdown of academic impact, for papers by Yusuf Kayar
Rankless by CCL
2026